Free tool
FAERS Monitor: Infasurf Preservative Free
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 020521 or its brand name (Infasurf Preservative Free, Calfactant). Reports on generic versions are filed under their own applications.
Reports
63
Serious
60
95% of reports
Hospitalization
7
Death reported
11
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- endotracheal intubation complication25
- oxygen saturation decreased13
- bradycardia6
- cardio-respiratory arrest5
- pneumothorax4
- death3
- heart rate decreased3
- neonatal hypoxia3
- obstruction3
- product quality issue3
- pulmonary haemorrhage3
- bradycardia neonatal2
- breath sounds absent2
- cardiac failure2
- cardio-respiratory arrest neonatal2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2013 | 16 |
| 2014 | 4 |
| 2015 | 10 |
| 2016 | 14 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,096 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| endotracheal intubation complicationSignal | 25 | 14787.3 | 10787.1 | 339,960 |
| cardio-respiratory arrest neonatal | 2 | 8794.5 | 2207.7 | 9,637 |
| breath sounds absent | 2 | 6188.7 | 1562.1 | 6,833 |
| neonatal hypoxiaSignal | 3 | 1216.7 | 402.4 | 2,521 |
| bradycardia neonatal | 2 | 532.2 | 135.9 | 595 |
| obstructionSignal | 3 | 250.9 | 83.1 | 517 |
| pulmonary haemorrhageSignal | 3 | 128.1 | 42.4 | 262 |
| pneumothoraxSignal | 4 | 84.3 | 32.6 | 251 |
| oxygen saturation decreasedSignal | 13 | 77.2 | 47.6 | 906 |
| cardio-respiratory arrestSignal | 5 | 39.9 | 17.2 | 153 |
| bradycardiaSignal | 6 | 37.8 | 17.7 | 180 |
| heart rate decreasedSignal | 3 | 28.5 | 9.5 | 55 |
| cardiac failure | 2 | 8.3 | 2.1 | 7 |
| product quality issueSignal | 3 | 7.4 | 2.4 | 11 |
| death | 3 | 1.2 | 0.4 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.